Trademark Information

Application ID
Status
Date of Application
20 August 2020
Classes
10
Proprietor
B 213 Pocket B, Okhla Phase I, Okhla Industrial Area,Phase I,New Delhi
Attorney
Shraddha Momaya[30080]
#E7,Suvidha Nestle, Keshwapur, Hubballi 580023
Type
Device
State
Delhi
Country
Filing Mode
e-Filing
IP Office
DELHI
Used Since
Valid / Upto
20 August 2030
Description
[Class : 10] Surgical, Medical, Dental And Veterinary Apparatus And Instruments, Artificial Limbs, Eyes And Teeth; Orthopedic Articles; Suture Materials; Manufacturers

Image (DEVICE)

S & S Surgicare Device mark 4617953 Trademark

Documents

Examination Report

Uploaded Documents

1 TM-A(TRADE MARKS APPLICATION) 20 Aug 2020
2 Reply to Exam Report (MIS-R) 22 Sep 2020
3 TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) 27 Dec 2023
4 Journal Copy 15 Jul 2024
5 Certificate 21 Oct 2024

Correspondence and Notices

1 EXAMINATION REPORT 10416057   15 Sep 2020
2 Hearing Notice (Show Cause) 15457523   20 Jun 2023
3 Hearing Notice (Show Cause) 16032282   13 Sep 2023
4 Hearing Notice (Show Cause) 16449272   03 Nov 2023
5 Hearing Notice (Show Cause) 17379591   12 Feb 2024
6 Tribunal Accepted Notice for : 4617953 17687975 6623323 11 Mar 2024

Frequently Asked Questions

What is the application date as per IP India website?

As per IP India data the trademark was applied on 20 August 2020.

Who has filed the trademark application with the TMO?

S S SURGICARE applied for S & s surgicare.

What is the listed class of the S & s surgicare with IP India?

Listed class of trademark S & s surgicare is 10.

As per IP india what is the stage of trademark application?

S & s surgicare is on the Registered stage of the trademark process.

What is the Serial number provided by the trademark data?

Serial Number provided to trademark application is 4617953

Who filed the trademark on behalf of the proprietor?

Trademark application was filed by the following attorney agent:
Shraddha Momaya

How is the S & s surgicare categorized?

The trademark is categorized as DEVICE.